Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019

Published 2020 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019
Authors
Keywords
COVID-19, SARS-CoV-2, Cytokine storm, Anti–PD-1, Anti–IL-6R, Pembrolizumab, Tocilizumab
Journal
EUROPEAN JOURNAL OF CANCER
Volume 135, Issue -, Pages 62-65
Publisher
Elsevier BV
Online
2020-06-04
DOI
10.1016/j.ejca.2020.05.026

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.